Clinical Trial

Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to compare the pharmacokinetics and safety of HDP023 and coadministration of Teneligliptin and Empagliflozin in healthy adult volunteers
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-30.
Status change: Not Yet Recruiting → Completed 2026-02-03
Trial Details
NCT Number NCT07102719
Lead Sponsor Handok Inc.
Conditions Healthy Volunteers
Enrollment 40 participants
Start Date 2025-09-10
Primary Completion 2025-10-20 (estimated)
Study Completion 2025-10-20 (estimated)
Updated on ClinicalTrials.gov 2026-02-05